Fund Holdings — Opaleye Management Inc.

Total Portfolio Value:
$757.89M
Total Bought:
$151.59M
Total Sold:
$139.76M
Net Transaction:
+$11.83M
Notable People:
James Aaron Silverman
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Harrow, Inc.(HROW)3,905,0003,905,0000$188.14M$191.34M25.25%+$3.20M
Liquidia Corporation(LQDA)2,615,0002,435,000-180,000$59.47M$84.98M11.21%+$25.52M
Eton Pharmaceuticals, Inc.(ETON)2,860,0002,860,0000$62.15M$48.36M6.38%-$13.79M
Rhythm Pharmaceuticals, Inc.(RYTM)461,700330,000-131,700$46.63M$35.32M4.66%-$11.30M
Apogee Therapeutics Inc363,257388,257+25,000$14.43M$29.31M3.87%+$14.87M
SANUWAVE Health, Inc.(SNWV)980,000981,267+1,267$36.73M$29.28M3.86%-$7.45M
Stoke Therapeutics, Inc.(STOK)682,017695,000+12,983$16.03M$22.06M2.91%+$6.03M
Ocular Therapeutix, Inc.(OCUL)1,595,0001,595,0000$18.65M$19.36M2.55%+$717.8K
Sol Gel TechnologiesSHS NEW
SHS NEW
204,835453,739+248,904$5.97M$19.12M2.52%+$13.15M
CG Oncology, Inc.(CGON)410,000410,0000$16.51M$17.02M2.25%+$508.4K
TG Therapeutics, Inc.(TGTX)535,000535,0000$19.33M$15.95M2.10%-$3.38M
Disc Medicine, Inc.(IRON)193,773200,000+6,227$12.80M$15.88M2.10%+$3.08M
Rezolute, Inc.(RZLT)903,4426,287,156+5,383,714$8.49M$14.84M1.96%+$6.35M
Crescent Biopharma, Inc.(CBIO)01,178,300+1,178,300$0$13.97M1.84%+$13.97M
Alkermes plcSHS(ALKS)450,000490,000+40,000$13.50M$13.71M1.81%+$210.2K
Alpha Cognition Inc. Common Stock(ACOG)115,1422,070,784+1,955,642$749.6K$13.46M1.78%+$12.71M
Annexon, Inc.(ANNX)2,600,0002,600,0000$7.93M$13.05M1.72%+$5.12M
Edgewise Therapeutics, Inc.(EWTX)500,000500,0000$8.11M$12.41M1.64%+$4.30M
Codexis, Inc.(CDXS)12,795,0006,789,738-6,005,262$31.22M$11.07M1.46%-$20.15M
Protagonist Therapeutics Inc105,000105,0000$6.98M$9.17M1.21%+$2.20M
Gossamer Bio, Inc.(GOSS)2,725,0002,720,000-5,000$7.17M$8.43M1.11%+$1.27M
MBX Biosciences, Inc.(MBX)253,000260,000+7,000$4.43M$8.20M1.08%+$3.77M
Revolution Medicines, Inc.(RVMD)100,000100,0000$4.67M$7.96M1.05%+$3.29M
Xoma Corp Del255,087292,590+37,503$9.83M$7.78M1.03%-$2.05M
Journey Medical Corporation(DERM)971,064975,000+3,936$6.91M$7.52M0.99%+$603.3K
Karyopharm Therapeutics Inc.(KPTI)0930,000+930,000$0$6.84M0.90%+$6.84M
Jade Biosciences Inc0427,608+427,608$0$6.60M0.87%+$6.60M
UroGen Pharma Ltd.(URGN)0268,423+268,423$0$6.29M0.83%+$6.29M
Alumis Inc665,000535,000-130,000$2.65M$5.22M0.69%+$2.57M
Perspective Therapeutics, Inc.(CATX)01,184,500+1,184,500$0$4.99M0.66%+$4.99M
Voyager Therapeutics, Inc.(VYGR)01,196,904+1,196,904$0$4.70M0.62%+$4.70M
Relmada Therapeutics, Inc.(RLMD)0935,000+935,000$0$4.52M0.60%+$4.52M
Tectonic Therapeutic, Inc.(TECX)0214,747+214,747$0$4.48M0.59%+$4.48M
Protalix BioTherapeutics, Inc.(PLX)2,580,5562,478,176-102,380$5.73M$4.46M0.59%-$1.27M
Trevi Therapeutics, Inc.(TRVI)390,000345,100-44,900$3.57M$4.32M0.57%+$752.2K
Fortress Biotech, Inc.(FBIO)01,090,000+1,090,000$0$3.99M0.53%+$3.99M
Rocket Pharmaceuticals, Inc.(RCKT)0955,000+955,000$0$3.35M0.44%+$3.35M
MeiraGTx Holdings plc(MGTX)0390,844+390,844$0$3.11M0.41%+$3.11M
Rigel Pharmaceuticals, Inc.(RIGL)37,78770,000+32,213$1.07M$3.00M0.40%+$1.93M
Zymeworks Inc.(ZYME)100,000108,929+8,929$1.71M$2.87M0.38%+$1.16M
Assertio Holdings Inc0285,000+285,000$0$2.58M0.34%+$2.58M
Ventyx Biosciences Inc0251,932+251,932$0$2.27M0.30%+$2.27M
Opus Genetics, Inc.(IRD)1,100,0001,120,000+20,000$1.81M$2.25M0.30%+$436.2K
Sutro Biopharma, Inc.(STRO)0190,671+190,671$0$2.21M0.29%+$2.21M
Cabaletta Bio, Inc.(CABA)808,882900,000+91,118$1.89M$1.97M0.26%+$78.2K
Zentalis Pharmaceuticals, Inc.(ZNTL)316,5501,400,906+1,084,356$478.0K$1.89M0.25%+$1.41M
Generation Bio Co0310,000+310,000$0$1.76M0.23%+$1.76M
BridgeBio Pharma, Inc.(BBIO)018,319+18,319$0$1.40M0.18%+$1.40M
Enanta Pharmaceuticals, Inc.(ENTA)075,000+75,000$0$1.18M0.16%+$1.18M
Q32 Bio Inc.(QTTB)0213,363+213,363$0$708.4K0.09%+$708.4K
Atea Pharmaceuticals, Inc.(AVIR)0179,815+179,815$0$641.9K0.08%+$641.9K
Silence Therapeutics plcADS(SLN)078,926+78,926$0$479.9K0.06%+$479.9K
Rapt Therapeutics Inc0150,000+150,000$0$213.4K0.03%+$213.4K
Adagio Medical Holdings, Inc.(ADGM)110,57118,444-92,127$214.5K$19.2K0.00%-$195.3K
ADC Therapeutics SASHS(ADCT)682,5290-682,529$2.73M$0—-$2.73M
Arvinas, Inc.(ARVN)987,8180-987,818$8.42M$0—-$8.42M
iBio, Inc.(IBIO)375,0000-375,000$310.4K$0—-$310.4K
Immunome, Inc.(IMNM)3,185,0000-3,185,000$37.30M$0—-$37.30M
Karyopharm Therapeutics IncNOTE 3 000 10 1000$4.63M$0—-$4.63M
Larimar Therapeutics, Inc.(LRMR)3,720,8670-3,720,867$10.56M$0—-$10.56M
PepGen Inc.(PEPG)75,0000-75,000$346.5K$0—-$346.5K
Sarepta Therapeutics, Inc.(SRPT)585,0000-585,000$11.27M$0—-$11.27M
Spyre Therapeutics, Inc.(SYRE)65,0000-65,000$1.09M$0—-$1.09M
Treace Medical Concepts, Inc.(TMCI)702,2450-702,245$4.71M$0—-$4.71M
Page 1 of 1
Opaleye Management Inc. — 13F Holdings — Q4 2025 | TickerTrail